Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.33859
Abstract: Key Points Question Can a previously validated clinical calculator be adapted to estimate the risk of rectal cancer recurrence dynamically at different time points for patients who defer surgery after complete response to neoadjuvant therapy?… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2022.33868
Abstract: Nonoperative management (watch and wait) is an emerging novel strategy for organ preservation in patients with rectal cancer. Nonoperative management for rectal cancer can be renamed as “surveillance with selective delayed surgery,” in which patients… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.52140
Abstract: This case series examines transcriptomic factors associated with outcomes in patients with rectal cancer who received neoadjuvant chemoradiotherapy. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2019.0186
Abstract: Importance Chemoradiotherapy (CRT), followed by surgery, is the recommended approach for stage II and III rectal cancer. While CRT decreases the risk of local recurrence, it does not improve survival and leads to poorer functional… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Applied Clinical Medical Physics"
DOI: 10.1002/acm2.13712
Abstract: Abstract Purpose To develop an automated workflow for rectal cancer three‐dimensional conformal radiotherapy (3DCRT) treatment planning that combines deep learning (DL) aperture predictions and forward‐planning algorithms. Methods We designed an algorithm to automate the clinical… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10879
Abstract: It is not clear whether all patients with rectal cancer need chemoradiotherapy. A restrictive use of neoadjuvant chemoradiotherapy (nCRT) based on MRI findings for rectal cancer was investigated in this study. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "British Journal of Surgery"
DOI: 10.1002/bjs.11200
Abstract: The optimal timing of surgery for rectal cancer after radiotherapy (RT) is disputed. The Stockholm III trial concluded that it was oncologically safe to delay surgery for 4–8 weeks after short‐course RT (SRT), with fewer postoperative… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "British Journal of Surgery"
DOI: 10.1002/bjs.11220
Abstract: The current standard of care in locally advanced rectal cancer (LARC) is neoadjuvant long‐course chemoradiotherapy (nCRT) followed by total mesorectal excision (TME). Surgery is conventionally performed approximately 6–8 weeks after nCRT. This study aimed to determine… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "British Journal of Surgery"
DOI: 10.1002/bjs.11324
Abstract: Neoadjuvant chemoradiotherapy (nCRT) for locally advanced rectal cancer may induce a pathological complete response (pCR) but increase surgical morbidity due to radiation‐induced fibrosis. In this study the association between pCR and postoperative surgical morbidity was… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "British Journal of Surgery"
DOI: 10.1002/bjs.11513
Abstract: Japan Clinical Oncology Group (JCOG) 0212 (ClinicalTrials.gov NCT00190541) was a non‐inferiority phase III trial of patients with clinical stage II–III rectal cancer without lateral pelvic lymph node enlargement. The trial compared mesorectal excision (ME) with… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "British Journal of Surgery"
DOI: 10.1002/bjs.11599
Abstract: Editor We would like to thank our colleagues Jia et al. for their thoughtful comments on our study of conversion in robotic versus laparoscopic rectal cancer surgery1. Risk factors for conversion depicted by our multivariate… read more here.